Patent · US Active

Implantable pump for direct sodium removal therapy having on-board analyte sensor

US11464891B2 · kind B2 · utility

0Cited by

207References

24Claims

0Family size

Assignee

Sequana Medical NV · CH

Inventors

Ian CROSBIE · London, GB
Andreas Wirth · Simbach, DE
Oliver Goedje · Deining, DE

Key dates

Filing date	Feb 7, 2022
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Feb 7, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2210/1085
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Systems and methods for performing Direct Sodium Removal (DSR) therapy are provided in which an implantable device includes a pump coupled to an inlet catheter designed for placement in a patient's peritoneal cavity, an outlet catheter designed to be coupled to the patient's bladder, and is operably coupled to an analyte sensor, the pump programmed to transfer and/or cease transfer of fluid from the patient's peritoneal cavity to the patient's bladder for voiding responsive to a level of analyte detected by the analyte sensor. In addition, the system may include a processor that computes an amount of analyte transferred per pumping session.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.